PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'(BuckInstitute for Researchon Aging), (Novato), (CA 94945), (United States).\', \'(Departmentof Immunology), (School of Medicine), (Mazandaran University of Medical Sciences), (Sari), (Iran).\', \'(Departmentof Immunology), (School of Medicine), (Mazandaran University of Medical Sciences), (Sari), (Iran); (StudentResearch Committee), (Mazandaran University of Medical Sciences), (Iran).\', \'(Departmentof Immunology), (School of Medicine), (Kermanshah University of Medical Sciences), (Kermanshah), (Iran). Electronic address: mtaghad@gmail.com.\', \'(BuckInstitute for Researchon Aging), (Novato), (CA 94945), (United States). Electronic address: pkapahi@buckinstitute.org.\']
?:citedBy
  • -1
?:creator
?:doi
  • S1567-5769(21)00442-210.1016/j.intimp.2021.107806
?:doi
?:hasPublicationType
?:journal
  • International immunopharmacology
is ?:pmid of
?:pmid
?:pmid
  • 34352471
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.051
?:rankingScore_hIndex
  • 94
is ?:relation_isRelatedTo_publication of
?:title
  • Advanced glycation end products (AGEs) and its receptor, RAGE, modulate age-dependent COVID-19 morbidity and mortality. A review and hypothesis.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all